Vulvitis: Clinical Trials

4 trials for Vulvitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 12Unknown 2
Phase 31Unknown 1

Follow Vulvitis: new trials by email Literature Review of Vulvitis trials Research Report on Vulvitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection
BGY-1601-VT, PLACEBO - Bacterial Vaginosis, Vulvovaginal Candidiasis
Phase 1 / Phase 2UnknownNEXBIOME THERAPEUTICS1652024-07-082024-06-12
A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis
Chlorhexidine Gluconate, Fluconazole - Candidiasis, Vulvovaginal
Phase 2UnknownKarolinska Institutet602022-04-272022-05-20
A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)
Prof-001, Fluconazole 150 mg, Placebo cream - Recurrent Vulvovaginal Candidiasis
Phase 2 / Phase 3UnknownProFem GmbH4322019-10-012022-09-22
Patients With Vulvovaginal Candidiasis
EPP-AF Gel 1%, EPP-AF Gel 2%, Clotrimazole - Vulvovaginal Candidiasis
Phase 1 / Phase 2UnknownUniversity of Sao Paulo902018-01-302018-10-19

Narrower conditions

Candidiasis, Vulvovaginal (4)  ·  Vaginitis (1)  ·  Vaginosis, Bacterial (1)  ·  Vulvovaginitis (1)

Broader conditions

Bacterial Infections and Mycoses (4)  ·  Candidiasis (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Infections (4)  ·  Mycoses (4)  ·  Urogenital Diseases (4)  ·  Vaginal Diseases (4)  ·  Vulvar Diseases (4)  ·  Vaginitis (3)  ·  Vulvovaginitis (3)  ·  Bacterial Infections (1)

Interventions

Fluconazole (2)  ·  Clotrimazole (1)  ·  chlorhexidine gluconate (1)

Sponsors

Karolinska Institutet (1)  ·  NEXBIOME THERAPEUTICS (1)  ·  ProFem GmbH (1)  ·  University of Sao Paulo (1)

Countries

Austria (1)  ·  Brazil (1)  ·  Poland (1)  ·  Slovakia (1)  ·  Sweden (1)

Top investigators

Cathrin Alvendal, MD, PhD (1)  ·  Herbert Kiss, Prof. (1)

Results publications

PMID 41845293